The Latest Cardiac and Vascular News
MORRISVILLE, N.C.–(BUSINESS WIRE)–Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need, today reported financial results for the year ended December 31, 2021 and provided a business update. “With the advancement of our […]
BRIDGEWATER, N.J., March 30, 2022 /PRNewswire/ — Nipro Medical Corporation (Nipro), a leading manufacturer and supplier of renal, vascular, and medical-surgical products, welcomes a second-gen Cronus® HP PTA Balloon Catheter to the U.S. Cronus® HP is a high pressure (HP) percutaneous transluminal angioplasty (PTA) balloon catheter indicated for use in popliteal, femoral, iliac, and renal […]
Transformative Shockwave C2 Intravascular Lithotripsy Catheter Will Soon Be Available in One of the World’s Largest Coronary Intervention Markets SANTA CLARA, Calif., March 30, 2022 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, announced today that […]
SUNNYVALE, Calif., March 29, 2022 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported financial results for the year ended December 31, 2021 and filed its annual report on Form 10-K for the year ended December 31, […]
Provides enhanced credit facility up to $100 million with favorable terms and facility maturity extended to March 2027 SAN FRANCISCO, March 29, 2022 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, announced it has amended its existing […]
Fourth quarter 2021 revenue of $23.0 million contributed to record full year revenue of $81.6 million, 46% growth over the prior year Established over 75 new customer accounts, expanding and diversifying revenue base Substantial cash and investments of $657.7 million at year-end Maintaining 2022 full year revenue guidance of $105-110 […]
The Biome Opportunity Engine™ leverages advanced machine learning to automatically identify and prioritize clinical and financial performance opportunities with the greatest impact on outcomes. SAN FRANCISCO–(BUSINESS WIRE)–Biome Analytics, the leading cardiovascular performance company, is pleased to introduce the Biome Opportunity Engine™. This groundbreaking solution enables cardiovascular service lines, at individual […]
TOLEDO, Ohio & DIEST, Belgium–(BUSINESS WIRE)–NAMSA, a world-leading MedTech Contract Research Organization (CRO) offering global end-to-end development services, announced today its nearing acquisition of Medanex Clinic, a Belgium-based European preclinical research organization. Founded in 2010, Medanex focuses on providing exceptional preclinical services to the medical device industry in Europe and across the globe. […]
SHANGHAI, March 28, 2022 /PRNewswire/ — Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. (Endovastec™) recently announced that it has received registration approval from Japan Pharmaceuticals and Medical Devices Agency (PMDA) for its independently-developed Hyperflex® Balloon Catheter (Hyperflex®) as the company’s first product approved for marketing in Japan. Hyperflex® obtained CE Mark in 2016 […]
EATONTOWN, N.J.–(BUSINESS WIRE)–Tractus Vascular, LLC today announced the first-in-man use of the TractusTM Crossing Support Catheter (TractusTM CSC). The TractusTM CSC represents a highly novel approach to treating vascular disease. Chronic total occlusion (CTO) remains one of the most challenging pathologies encountered by surgeons and interventionalists in performing endovascular interventions. Drs. John H. Rundback […]
